Monday Morning Preview

I'm up studying for a test, so might as well update with some market news. I have a feeling this week is going to be full of action.

• ELN successfully completes safety review of Tysabri in Crohns and RA. This isn't surprising news, but it's good news. There are rumors (per analysts) that an FDA decision on whether or not to grant priority review for its sBLA application will take place by the end of the month.
• Another hurricane on the way!
• Oil is trading up because of this hurricane threat.
• Refco's future is not bright.
• Don't forget to syndicate the RSS feed. If you don't have an RSS reader, sign up for Bloglines.
• STEM, NVAX, AVII, ANSI, RNWK are trading upwards with noticable volume premarket.

With the Nasdaq and NYSE in a precarious position, this hurricane and crude oil news can't be good. Keep those energy stocks on your watchlists this week. Later, back to studying.